Pharmaceutical compositions of o-nitro compounds
AssigneesRadiorx, Inc., C/O Interwest Venture Partners, Alliant Techsystems Inc.
InventorsMark D. Bednarski, Lynn M. Oehler, Susan Knox, Louis Cannizzo, Kirstin Warner, Robert Wardle, Stephen Velarde, Shoucheng Ning
Life of this patent
Estimating the term…
Abstract
The present invention provides O-nitro compounds, pharmaceutical compositions of O-nitro compounds and methods of using O-nitro compounds and/or pharmaceutical compositions thereof to treat or prevent diseases or disorders characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease and autoimmune disease.
Claims18
A pharmaceutical composition comprising at least one O-nitro compound or a pharmaceutically acceptable salt, hydrate or solvate thereof, and a pharmaceutically acceptable vehicle.
(canceled)
-18. (canceled)
Dependencies are inferred from the claim text.